Clinical trial against the consequences of chikungunya begins in Matanzas
Matanzas, one of the Cuban epicenters of the chikungunya epidemic, began this Wednesday a clinical trial with the drug Jusvinza for the treatment of residual polyarthritis in patients convalescent from such disease.